About 22nd century group inc - XXII
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco segment. The Tobacco segment manufactures branded filtered cigars and cigarettes. The company was founded on September 12, 2005 and is headquartered in Mocksville, NC.
XXII At a Glance
22nd Century Group, Inc.
321 Farmington Road
Mocksville, North Carolina 27028
| Phone | 1-336-940-3769 | Revenue | 17.59M | |
| Industry | Biotechnology | Net Income | -5,054,000.00 | |
| Sector | Health Technology | Employees | 32 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
XXII Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.121 |
| Price to Book Ratio | 0.374 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.079 |
| Enterprise Value to Sales | -0.046 |
| Total Debt to Enterprise Value | -5.186 |
XXII Efficiency
| Revenue/Employee | 549,593.75 |
| Income Per Employee | -157,937.50 |
| Receivables Turnover | 4.893 |
| Total Asset Turnover | 0.722 |
XXII Liquidity
| Current Ratio | 2.425 |
| Quick Ratio | 1.83 |
| Cash Ratio | 0.983 |
XXII Profitability
| Gross Margin | -20.242 |
| Operating Margin | -64.912 |
| Pretax Margin | -74.743 |
| Net Margin | -28.737 |
| Return on Assets | -53.873 |
| Return on Equity | -132.696 |
| Return on Total Capital | -65.687 |
| Return on Invested Capital | -86.836 |
XXII Capital Structure
| Total Debt to Total Equity | 26.723 |
| Total Debt to Total Capital | 21.088 |
| Total Debt to Total Assets | 15.583 |
| Long-Term Debt to Equity | 24.362 |
| Long-Term Debt to Total Capital | 19.225 |